NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Lassen Therapeutics

Lassen Therapeutics

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://lassentherapeutics.com/

Last Round

Series B

Dec 19, 2023

Total Funding Raised

$116M

Company Overview

Lassen Therapeutics is a biopharmaceutical company that develops antibody-based therapeutics for the treatment of fibrotic, inflammatory, and oncology-related diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

monoclonal antibodybiotechfibrosis treatmentIL-11 pathwayclinical-stage biotechthyroid eye diseasedrug developmentbiopharmatherapeutic antibodyfibrotic diseaseoncologydrug discoveryclinical trialsrare disease

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lassen Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Lassen Therapeutics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Lassen Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BDec 19, 2023
Series AJun 17, 2020

Key People

Founding team and executive leadership

Mark Barrett

Founder, CEO Board Member (2018-23) Advisor (current)

Founding Team

Lassen Therapeutics Investors

Notable investors and investment history

Lassen Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Lassen Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lassen Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range14
Year Founded2018
Last FundingDec 19, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.